Boothbay Fund Management, LLC Krystal Biotech, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$96.0 - $128.29 $2.3 Million - $3.08 Million
24,000 New
24,000 $2.98 Million
Q4 2021

Feb 14, 2022
SELL
$39.81 - $88.24 $1.11 Million - $2.47 Million
-28,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$52.01 - $71.77 $1.46 Million - $2.01 Million
28,000 New
28,000 $1.46 Million

Others Institutions Holding KRYS

# of Institutions
266
Shares Held
25M
Call Options Held
270K
Put Options Held
172K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.55B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email